Ahlstrom January-March 2015 interim report: Clear improvement in operating profit driven by better pricing and product mix

Ahlstrom Corporation STOCK EXCHANGE RELEASE April 28, 2015 at 08.30

This is a summary of the January-March 2015 interim report. The complete report with tables is attached to this release and available at www.ahlstrom.com

Ahlstrom January-March 2015 interim report

Clear improvement in operating profit driven by better pricing and product mix

January-March 2015 compared with January-March 2014

  • Net sales EUR 271.8 million (EUR 249.2 million), showing an increase of 9.1%.

  • Operating profit excluding non-recurring items EUR 12.0 million (EUR 7.2 million).

  • Operating margin excluding non-recurring items 4.4% (2.9%).

  • Profit before taxes EUR 13.8 million (EUR 5.2 million), including a EUR 6 million capital gain booked from the sale of Munksjö Oyj shares.

  • Earnings per share EUR 0.17 (EUR 0.05).

  • Comparable net sales at constant currencies remained flat, as better pricing and product mix were offset by lower volumes. Reported net sales growth was primarily driven by a favorable currency effect.

  • Sixth consecutive quarter of year-on-year improvement in profitability excluding non-recurring items as Filtration, and Food and Medical businesses continued to improve their performance.

Outlook for 2015

  • Ahlstrom reiterates the outlook published on January 29, 2015. The company expects net sales in 2015 to be in the range of EUR 1,000-1,100 million. The operating profit margin excluding non-recurring items is expected to be 3.5-5% of net sales.

Key figures

EUR million

Q1/2015

Q1/2014

Change, %

2014

Net sales

271.8

249.2

9.1

1,001.1

EBITDA excl. NRI

26.2

18.9

38.6

78.6

% of net sales

9.6

7.6

7.9

Operating profit

12.7

4.4

188.6

-3.7

% of net sales

4.7

1.8

-0.4

Operating profit excl. NRI

12.0

7.2

66.5

28.6

% of net sales

4.4

2.9

2.9

Profit before taxes

13.8

5.2

167.7

-9.4

Profit for the period

8.8

3.1

188.0

-10.3

Earnings per share

0.17

0.05

N/A

-0.22

Return on capital employed, %

8.1

3.4

-0.5

Net cash flow from operative activities*

-1.5

-6.1

74.8

35.4

Capital expenditure

3.0

9.0

-66.3

45.4

Interest-bearing net liabilities*

254.0

281.3

-9.7

253.8

Gearing ratio*, %

74.0

87.7

79.3

Equity ratio*, %

34.3

32.4

34.8

Number of personnel, at the end of period

3,381

3,502

-3.5

3,401

EBITDA = operating profit before depreciation and amortization, excluding non-recurring items
* Including discontinued operations.

Marco Levi, President & CEO

"We continued to improve our financial performance in the quarter, driven by improved results in the Filtration and the Food and Medical business areas. We have seen a positive impact from our enhanced pricing and product mix, while foreign currency fluctuations also had a positive impact. The Building and Energy business area suffered from low volumes and an adverse currency effect.